Katherine C. Pierson
- Immunology top 1%
- Dermatology top 0.5%
- Oncology top 10%
- Physiology top 5%
- Molecular Biology
- Co-authors
- Michelle A. LowesJames G. KruegerJudilyn Fuentes‐DuculanLisa C. ZabaMayte Suárez‐FariñasJuana GonzalezInna NovitskayaKristine Nograles
- Topics
- Psoriasis: Treatment and Pathogenesis (8 papers)Immunotherapy and Immune Responses (5 papers)Dermatology and Skin Diseases (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Katherine C. Pierson
13 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology 1.7k
- Dermatology 917
- Oncology 451
- Physiology 423
- Molecular Biology 406
Countries citing papers authored by Katherine C. Pierson
This map shows the geographic impact of Katherine C. Pierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine C. Pierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine C. Pierson more than expected).
Fields of papers citing papers by Katherine C. Pierson
This network shows the impact of papers produced by Katherine C. Pierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine C. Pierson. The network helps show where Katherine C. Pierson may publish in the future.
Co-authorship network of co-authors of Katherine C. Pierson
This figure shows the co-authorship network connecting the top 25 collaborators of Katherine C. Pierson. A scholar is included among the top collaborators of Katherine C. Pierson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine C. Pierson. Katherine C. Pierson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 40 | |
| 3 | 95 | |
| 4 | 25 | |
| 5 | 288 | |
| 6 | 30 | |
| 7 | 163 | |
| 8 | 232 | |
| 9 | 92 | |
| 10 | 87 | |
| 11 | 77 | |
| 12 | 347 | |
| 13 | Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathwaysbreakdown → | 665 |
| 14 | 1 |
About Katherine C. Pierson
Katherine C. Pierson is a scholar working on Immunology, Dermatology and Immunology and Allergy, having authored 14 papers that have together received 2.2k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (8 papers), Immunotherapy and Immune Responses (5 papers) and Dermatology and Skin Diseases (4 papers). The work is most often cited by research in Dermatology (917 citations), Immunology (1.7k citations) and Immunology and Allergy (123 citations). Katherine C. Pierson has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Michelle A. Lowes, James G. Krueger, Judilyn Fuentes‐Duculan, Lisa C. Zaba, Mayte Suárez‐Fariñas, Juana Gonzalez, Inna Novitskaya, Kristine Nograles, Irma Cardinale and Narat J. Eungdamrong. Their work appears in journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.